Spanish competition agency vetoes “competition threatening” radiopharma deal
Spain’s competition agency (CNMC) has prohibited Curium Pharma Holding Spain (Curium), a global leader in nuclear medicine, from acquiring Institut de Radiofarmacia Aplicada de Barcelona (IRAB). It said on Monday, October 6 that the merger poses an obstacle to effective competition in the markets for PET radiopharmaceuticals which are used in cancer detection tests, and contract manufacturing services to third…